BACKGROUND: Isolated non-compaction cardiomyopathy (NCCM) was first described in 1984. This disorder, a primary genetic cardiomyopathy, is now attracting increased attention. METHOD: The current state of the epidemiology, pathogenesis, pathophysiology, clinical features, diagnosis, treatment, and prognosis of NCCM are discussed on the basis of a review of selected literature as well as the authors' personal experience. RESULTS: The pathogenesis of NCCM is thought to involve a genetically determined disturbance of the myocardial compaction process during fetal endomyocardial morphogenesis. It is not accompanied by any other cardiac anomalies. Echocardiography is the diagnostic method of choice. The diagnosis is based on the following echocardiographic criteria: the presence of at least 4 prominent trabeculations and deep intertrabecular recesses, blood flow from the ventricular cavity into the intertrabecular recesses, and a typical bilaminar structure of the affected portion of the left ventricular myocardium. NCCM can also be diagnosed with magnetic resonance imaging of the heart. The clinical severity of NCCM is variable; its manifestations include heart failure, thromboembolic events, and arrhythmias. The treatment is symptom-based. Patients with symptomatic NCCM have a poor prognosis. CONCLUSION: NCCM is a type of cardiomyopathy that was first described 25 years ago. Its molecular genetic basis is not yet fully clear, and the same is true of its diagnosis, treatment, and prognosis. Further study of these matters is needed.
BACKGROUND: Isolated non-compaction cardiomyopathy (NCCM) was first described in 1984. This disorder, a primary genetic cardiomyopathy, is now attracting increased attention. METHOD: The current state of the epidemiology, pathogenesis, pathophysiology, clinical features, diagnosis, treatment, and prognosis of NCCM are discussed on the basis of a review of selected literature as well as the authors' personal experience. RESULTS: The pathogenesis of NCCM is thought to involve a genetically determined disturbance of the myocardial compaction process during fetal endomyocardial morphogenesis. It is not accompanied by any other cardiac anomalies. Echocardiography is the diagnostic method of choice. The diagnosis is based on the following echocardiographic criteria: the presence of at least 4 prominent trabeculations and deep intertrabecular recesses, blood flow from the ventricular cavity into the intertrabecular recesses, and a typical bilaminar structure of the affected portion of the left ventricular myocardium. NCCM can also be diagnosed with magnetic resonance imaging of the heart. The clinical severity of NCCM is variable; its manifestations include heart failure, thromboembolic events, and arrhythmias. The treatment is symptom-based. Patients with symptomatic NCCM have a poor prognosis. CONCLUSION: NCCM is a type of cardiomyopathy that was first described 25 years ago. Its molecular genetic basis is not yet fully clear, and the same is true of its diagnosis, treatment, and prognosis. Further study of these matters is needed.
Authors: Ross T Murphy; Rajesh Thaman; Juan Gimeno Blanes; Deirdre Ward; Elias Sevdalis; Efi Papra; Anatoli Kiotsekoglou; Anatoli Kiotsekolglou; Maria T Tome; Denis Pellerin; William J McKenna; Perry M Elliott Journal: Eur Heart J Date: 2004-11-30 Impact factor: 29.983
Authors: Robert M Freedom; Shi-Joon Yoo; Don Perrin; Glenn Taylor; Steffen Petersen; Robert H Anderson Journal: Cardiol Young Date: 2005-08 Impact factor: 1.093
Authors: Steffen E Petersen; Joseph B Selvanayagam; Frank Wiesmann; Matthew D Robson; Jane M Francis; Robert H Anderson; Hugh Watkins; Stefan Neubauer Journal: J Am Coll Cardiol Date: 2005-07-05 Impact factor: 24.094
Authors: Mark T Johnson; Shaoxiong Zhang; Robert Gilkeson; Rebecca Ameduri; Ernest Siwik; Chandrakant R Patel; Oleg Chebotarev; Alexander B Kenton; Karla R Bowles; Jeffrey A Towbin; Nathaniel H Robin; Frank Brozovich; Brian D Hoit Journal: Am Heart J Date: 2006-05 Impact factor: 4.749
Authors: Katrin Brandner; David U Mick; Ann E Frazier; Rebecca D Taylor; Chris Meisinger; Peter Rehling Journal: Mol Biol Cell Date: 2005-08-31 Impact factor: 4.138
Authors: Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young Journal: Circulation Date: 2006-03-27 Impact factor: 29.690
Authors: T Luijkx; M J Cramer; A Zaidi; R Rienks; P J Senden; S Sharma; F J van Hellemondt; C F Buckens; W P Mali; B K Velthuis Journal: Neth Heart J Date: 2012-10 Impact factor: 2.380
Authors: Tamara Glavinovic; David Y C Cheung; Francisco J Cordova Perez; Anita Soni; Brett Memauri; Davinder S Jassal Journal: BMC Res Notes Date: 2014-11-05